# ![@Roche Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::20815041.png) @Roche Roche

Roche posts on X about $rog, $rhhby, media, people with the most. They currently have [-------] followers and [---] posts still getting attention that total [---] engagements in the last [--] hours.

### Engagements: [---] [#](/creator/twitter::20815041/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::20815041/c:line/m:interactions.svg)

- [--] Week [-----] -2.40%
- [--] Month [-----] -11%
- [--] Months [---------] +455%
- [--] Year [---------] +5,889%

### Mentions: [--] [#](/creator/twitter::20815041/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::20815041/c:line/m:posts_active.svg)

- [--] Week [--] -20%
- [--] Month [--] -44%
- [--] Months [---] +320%
- [--] Year [---] +178%

### Followers: [-------] [#](/creator/twitter::20815041/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::20815041/c:line/m:followers.svg)

- [--] Week [-------] -0.02%
- [--] Month [-------] -0.09%
- [--] Months [-------] -1.10%
- [--] Year [-------] -2%

### CreatorRank: [---------] [#](/creator/twitter::20815041/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::20815041/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[cryptocurrencies](/list/cryptocurrencies)  [finance](/list/finance)  [countries](/list/countries)  [stocks](/list/stocks)  [travel destinations](/list/travel-destinations)  [technology brands](/list/technology-brands) 

**Social topic influence**
[$rog](/topic/$rog) #1, [$rhhby](/topic/$rhhby) #4, [media](/topic/media), [people with](/topic/people-with), [we are](/topic/we-are), [approved](/topic/approved), [iii](/topic/iii), [data](/topic/data), [share](/topic/share), [acquisition](/topic/acquisition)

**Top accounts mentioned or mentioned by**
[@yachmod](/creator/undefined) [@mikeycolombia33](/creator/undefined) [@novonordisk](/creator/undefined) [@genentech](/creator/undefined) [@sciencecareers](/creator/undefined) [@hubrecht](/creator/undefined) [@ihbresearch](/creator/undefined) [@hans](/creator/undefined) [@who](/creator/undefined) [@nejm](/creator/undefined) [@businessatoecd](/creator/undefined) [@g7](/creator/undefined) [@cdnchamberofcom](/creator/undefined) [@isedca](/creator/undefined) [@innovativemeds](/creator/undefined) [@admarebio](/creator/undefined) [@sanofi](/creator/undefined) [@orencsak](/creator/undefined) [@canadabusiness](/creator/undefined) [@francolombo2019](/creator/undefined)

**Top assets mentioned**
[ROGin AI (ROG)](/topic/$rog) [Illumina, Inc. (ILMN)](/topic/illumina-inc) [Sanofi (SNY)](/topic/sanofi)
### Top Social Posts
Top posts by engagements in the last [--] hours

"We are excited to announce todays exclusive collaboration and licensing agreement with Zealand Pharma to co-develop and co-commercialise their amylin-analog as a monotherapy as well as in combination with our key incretin asset. $ROG $RHHBY Read more: https://go.roche.com/spndr25mr https://go.roche.com/spndr25mr"  
[X Link](https://x.com/Roche/status/1899703916712866024)  2025-03-12T06:08Z 238.3K followers, [----] engagements


"Roche launches new digital solution designed to simplify blood gas analysis and improve patient care. $ROG $RHBBY https://go.roche.com/bgt https://go.roche.com/bgt"  
[X Link](https://x.com/Roche/status/1261160131401637889)  2020-05-15T05:03Z 239.8K followers, [--] engagements


"Roche sales increase by 5% (CER) in first half of 2024; strong growth in second quarter full-year earnings outlook raised. For more details on our performance click here ➡ $ROG $RHHBY #RocheFinancialResults http://spkl.io/60114CQdd http://spkl.io/60114CQdd"  
[X Link](https://x.com/Roche/status/1816350960484049074)  2024-07-25T05:53Z 239.1K followers, [----] engagements


"#MEDIA We are excited to announce that the pre-filled syringe of our bispecific antibody has received approval from the European Commission for the treatment of three leading causes of #VisionLoss - nAMD DME and RVO. $ROG $RHHBY http://spkl.io/6011fwxez http://spkl.io/6011fwxez"  
[X Link](https://x.com/Roche/status/1867460778082627735)  2024-12-13T06:45Z 238.6K followers, [----] engagements


"🩺 Cancer patients deserve informed fertility choices before treatment. BeyondX empowers this journey. #TogetherForChange #XProject Learn more at: http://spkl.io/6015fwNrN http://spkl.io/6015fwNrN"  
[X Link](https://x.com/Roche/status/1867857063491055769)  2024-12-14T09:00Z 239.8K followers, [----] engagements


"🌟I am grateful to have the opportunity to do what I love and make an impact on peoples lives says Tebogo a South African nurse who owns her own clinic through a local partnership.#TogetherForChange #XProject #Partnerships Discover Tebogo's story at: http://spkl.io/6016fbFAu http://spkl.io/6016fbFAu"  
[X Link](https://x.com/Roche/status/1869374243139448895)  2024-12-18T13:28Z 239.8K followers, [----] engagements


"🌟 Rutas Saludables is delivering vital health screenings directly to women in rural Colombia who need them most. #TogetherForChange #XProject #Partnerships Discover more at: https://spkl.io/6018fii6k https://spkl.io/6018fii6k"  
[X Link](https://x.com/Roche/status/1888135685799858557)  2025-02-08T08:00Z 239.7K followers, [----] engagements


"#MEDIA - We are pleased to present our novel #SequencingbyExpansion (SBX) technology creating a new category of NGS. The breakthrough SBX technology offers ultra-rapid high-throughput sequencing that is both flexible and scalable. $ROG $RHHBY https://go.roche.com/sbxpr20 https://go.roche.com/sbxpr20"  
[X Link](https://x.com/Roche/status/1892644395616190695)  2025-02-20T18:36Z 238.5K followers, [----] engagements


"#MEDIA We are pleased the U.S. FDA has accepted the supplemental Biologics License Application for our anti-CD20 monoclonal antibody offering a potential new treatment option for people with active #LupusNephritis. $ROG $RHHBY https://spkl.io/6011fqPx5 https://spkl.io/6011fqPx5"  
[X Link](https://x.com/Roche/status/1897191845198807124)  2025-03-05T07:45Z 238.6K followers, [----] engagements


"#MEDIA We are pleased the CHMP has recommended EU approval of a subcutaneous formulation of our bispecific antibody potentially expanding the treatment options available for people with follicular #lymphoma $RHHBY $ROG https://spkl.io/6017ArJ5S https://spkl.io/6017ArJ5S"  
[X Link](https://x.com/Roche/status/1969026516693467413)  2025-09-19T13:11Z 240.5K followers, [----] engagements


"#MEDIA - At #ECTRIMS2025 were sharing new research on disability progression across broad MS populations. The findings reaffirm our collective commitment to advancing science and improving outcomes for the MS community. $RHHBY $ROG https://spkl.io/6018Arf6s https://spkl.io/6018Arf6s"  
[X Link](https://x.com/Roche/status/1970750642361688433)  2025-09-24T07:22Z 240.5K followers, [----] engagements


"Data show Roches innovations deliver improved sensitivity and accuracy for faster and more reliable diagnosis in emergencies helping clinicians quickly identify heart attack and rule out non-cardiac causes: $RHHBY $ROG https://spkl.io/6011ATvAF https://spkl.io/6011ATvAF"  
[X Link](https://x.com/Roche/status/1972892919838158914)  2025-09-30T05:15Z 238.6K followers, [----] engagements


"#MEDIA The US FDA has approved our #immunotherapy treatment regimen for extensive-stage small cell #lungcancer (ES-SCLC) where maintenance therapy may help combat the risk of progression $ROG $RHHBY https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/Roche/status/1974048466197233907)  2025-10-03T09:46Z 240.5K followers, [----] engagements


"#MEDIA - We are pleased the CHMP has recommended approval of our investigational medicine for adults with #lupusnephritis potentially helping to address the high unmet need for new treatment options if approved. $ROG $RHHBY https://spkl.io/6014AXyZQ https://spkl.io/6014AXyZQ"  
[X Link](https://x.com/Roche/status/1979142166388560044)  2025-10-17T11:07Z 238.6K followers, [----] engagements


"#MEDIA - At #ESMO25 well be presenting results from the first positive head-to-head phase III trial of an all-oral #SERD-containing regimen vs. a standard of care combination in ER-positive advanced #BreastCancer $ROG $RHHBY https://spkl.io/6017AXTKc https://spkl.io/6017AXTKc"  
[X Link](https://x.com/Roche/status/1979526487502938135)  2025-10-18T12:34Z 240.5K followers, [----] engagements


"#MEDIA - We are pleased our phase III data at #ESMO25 show personalised ctDNA-guided treatment can deliver significant survival benefits for people with muscle-invasive #bladdercancer $ROG $RHHBY https://spkl.io/6014AXiLe https://spkl.io/6014AXiLe"  
[X Link](https://x.com/Roche/status/1980242600318599382)  2025-10-20T12:00Z 240.5K followers, [----] engagements


"#MEDIA Roche continues strong sales growth momentum of 7% (CER) in the first nine months of 2025; full-year earnings outlook raised. For more details on our performance click here ➡ https://spkl.io/6016Akywm https://spkl.io/6016Akywm"  
[X Link](https://x.com/Roche/status/1981225630722064714)  2025-10-23T05:06Z 240.5K followers, [----] engagements


"🚀 #ProudMoment Roche and @Genentech have been recognized among the worlds top #BioPharma employers in @ScienceMagazine [----] list Congratulations to all our teams 👏💙 Read more about it here 👉🔗 #SCTopEmployers #InnovationInHealthcare #science #biopharma @sciencecareers https://spkl.io/6017AkT2d https://spkl.io/6017AkT2d https://spkl.io/6017AkT2d https://spkl.io/6017AkT2d"  
[X Link](https://x.com/Roche/status/1981437437327946003)  2025-10-23T19:07Z 240.5K followers, [----] engagements


"#MEDIA We are excited to share positive results from our phase III trial in children and young adults with idiopathic nephrotic syndrome the first global phase III study of a targeted therapy in this chronic disease. $ROG $RHHBY https://spkl.io/6015AZJmL https://spkl.io/6015AZJmL"  
[X Link](https://x.com/Roche/status/1983161107024855430)  2025-10-28T13:17Z 238.6K followers, [----] engagements


"New test delivers results in half the time or less compared to current comparable solutions enabling faster patient management that can lower the risk of severe illness. $RHHBY $ROG https://www.roche.com/media https://www.roche.com/media"  
[X Link](https://x.com/Roche/status/1983417265237221501)  2025-10-29T06:15Z 238.6K followers, [----] engagements


"#MEDIA We are excited to share positive results from our phase III trial in systemic lupus erythematosus a potentially life-threatening autoimmune disease that affects more than three million people worldwide. 👉 $ROG $RHHBY https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/Roche/status/1985275041995518267)  2025-11-03T09:17Z 238.6K followers, [----] engagements


"#MEDIA - Were pleased to share positive Phase III results for our investigational oral brain-penetrant medicine in primary progressive and relapsing forms of multiple sclerosis. $RHHBY $ROG https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/Roche/status/1987770342996160751)  2025-11-10T06:32Z 238.4K followers, [----] engagements


"#MEDIA Were pleased to share phase III results from the first oral #SERD to show significant invasive-disease free survival benefit in ER-positive early-stage #BreastCancer. 👉 $ROG $RHHBY https://spkl.io/6012Ajh6g https://spkl.io/6012Ajh6g"  
[X Link](https://x.com/anyuser/status/1990663764157272554)  2025-11-18T06:10Z 238.3K followers, [----] engagements


"#MEDIA Were pleased to announce that the EC has approved our bispecific cancer immunotherapy for subcutaneous use in relapsed or refractory #lymphoma providing an additional treatment option to suit diverse patient and physician needs. 👉 https://spkl.io/6016AduYQ https://spkl.io/6016AduYQ"  
[X Link](https://x.com/anyuser/status/1991084695019294811)  2025-11-19T10:02Z 238.3K followers, [----] engagements


"Our #ChangingDiabetesInChildren initiative in collaboration with @novonordisk has spent [--] years empowering T1D care in resource-limited countries through education & access. Now we're leveraging evidence-based insights to embed sustainable care into national health plans. Witness our impact: #diabetesinchildren #DiabetesCare #HealthEquity https://go.roche.com/cdicx https://go.roche.com/cdicx"  
[X Link](https://x.com/anyuser/status/1994058636331458634)  2025-11-27T15:00Z 238.3K followers, [----] engagements


"As the needs and expectations of people living with haemophilia A continue to evolve Roches John Pasi explores how we can build on past breakthroughs to deliver more personalised care. Read the full story 👉 #HaemophiliaA #ASH2025 #PatientCentricity #InnovationInCare https://spkl.io/6015AgLZX https://spkl.io/6015AgLZX"  
[X Link](https://x.com/anyuser/status/1997924106818191805)  2025-12-08T07:00Z 238.3K followers, [----] engagements


"#MEDIA Were pleased to share three-year follow-up data from our off-the-shelf bispecific-combination which reinforce its potential to improve outcomes for people with an aggressive form of #lymphoma #ASH25 👉 $ROG $RHHBY https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/anyuser/status/1998054403593343467)  2025-12-08T15:37Z 238.3K followers, [----] engagements


"#MEDIA Were pleased to present new data highlighting the potential of our fixed-duration bispecific antibody in earlier treatment lines for people living with indolent and aggressive #lymphoma #ASH25 👉 $ROG $RHHBY https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/anyuser/status/1998286492460880242)  2025-12-09T07:00Z 238.3K followers, [----] engagements


"@novonordisk 💙"  
[X Link](https://x.com/Roche/status/2001314173263761780)  2025-12-17T15:30Z 238.6K followers, [--] engagements


"Duchenne muscular dystrophy (DMD) is a rare genetic condition which is estimated to impact [--] in every [----] [----] male births every year. This #RareDiseaseDay join us in raising awareness of #DMD"  
[X Link](https://x.com/Roche/status/1496175453836513280)  2022-02-22T17:30Z 238.4K followers, [--] engagements


"#MEDIA - Roche to present more than [--] abstracts at #ASH24 including long-term follow-up data for its lymphoma medicines studies exploring alternative routes of administration and new investigational combinations in earlier treatment lines. $RHHBY $ROG http://spkl.io/6011fTeuh http://spkl.io/6011fTeuh"  
[X Link](https://x.com/Roche/status/1853809271776903184)  2024-11-05T14:39Z 238.3K followers, [----] engagements


"We are thrilled to celebrate our member company Chugai Pharmaceuticals 100th anniversary today Our alliance has brought benefits to patients worldwide. Here's to [---] more years of innovation 🎉 Learn more at: #Chugai100thAnniversary #Roche https://spkl.io/6016fSJAi https://spkl.io/6016fSJAi"  
[X Link](https://x.com/Roche/status/1899016214967353478)  2025-03-10T08:35Z 238.3K followers, [----] engagements


"#MEDIA - We are pleased our medicine for adults with active #lupusnephritis is approved in the EU providing those living with this potentially life-threatening disease with a much-needed new treatment option and potential new standard of care. $ROG $RHHBY https://spkl.io/6012A9kmi https://spkl.io/6012A9kmi"  
[X Link](https://x.com/anyuser/status/1998327720976031844)  2025-12-09T09:43Z 238.3K followers, [----] engagements


"We fully agree that holistic cancer care must address the entire patient journey including essential access to pain relief and palliative care. Supporting balanced policies ensures that medical innovation is matched by compassionate accessible support for those who need it most. #WorldCancerDay #UnitedByUnique Ana at Team Roche https://twitter.com/i/web/status/2019113564846325802 https://twitter.com/i/web/status/2019113564846325802"  
[X Link](https://x.com/Roche/status/2019113564846325802)  2026-02-04T18:19Z 238.3K followers, [---] engagements


"MEDIA - Were pleased to share new Phase III data at #ACTRIMSForum for our investigational medicine in primary progressive multiple sclerosis. $RHHBY $ROG https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/anyuser/status/2020436289854824688)  2026-02-08T09:55Z 238.3K followers, [----] engagements


"The future of faster drug discovery may be on the horizon. #Organoids tiny simplified versions of human tissues help us test potential medicines in faster more predictive ways. A new review with @Hubrecht Institute explores how. 👏 Thank you to the scientists driving this work. Read more 👉 #DrugDiscovery #Innovation #pRED @IHB_Research @Hans Clevers https://spkl.io/6017Ai1dt https://spkl.io/6017Ai1dt"  
[X Link](https://x.com/anyuser/status/1999373655956918700)  2025-12-12T07:00Z 238.3K followers, [----] engagements


"Roche reports strong [----] results with 7% (CER) sales growth driven by strong demand for medicines and diagnostic solutions. 👉 Read the full release here: $ROG $RHHBY #FinancialResults https://spkl.io/6010AqN8r https://spkl.io/6010AqN8r"  
[X Link](https://x.com/anyuser/status/2016753185507901622)  2026-01-29T06:00Z 238.3K followers, [----] engagements


"Whooping cough (pertussis) results with PCR-level accuracy are now available at the point of care enabling primary care clinicians & emergency departments to act quickly treat appropriately prevent complications and control further spread. $RHHBY $ROG https://www.roche.com/media https://www.roche.com/media"  
[X Link](https://x.com/anyuser/status/1995771269510201395)  2025-12-02T08:25Z 238.3K followers, [----] engagements


"#MEDIA We are pleased to announce that the US FDA has approved our bispecific antibody for subcutaneous administration for people with relapsed or refractory #lymphoma reducing administration time from 2-4 hours to approximately one minute. $RHHBY $ROG https://spkl.io/6011AY8Af https://spkl.io/6011AY8Af"  
[X Link](https://x.com/anyuser/status/2003046611946021352)  2025-12-22T10:15Z 238.3K followers, [----] engagements


"The leap to tomorrow is today 🚀 Roche's new Diagnostics Innovation Center in Penzberg Germany is now officially open. This 300M investment is a massive step for innovation designed for collaboration and digitalization to accelerate test development. Better diagnostics = better lives for patients globally: #Innovation #LEAP #Penzberg #Healthcare #Technology https://go.roche.com/leapx https://go.roche.com/leapx"  
[X Link](https://x.com/anyuser/status/2021880120340889656)  2026-02-12T09:32Z 238.3K followers, [----] engagements


"Roche Releases More Evrysdi Data For Very Young Infants With SMA - Roche Holding (OTC:RHHBF) Roche Holding (OTC:RHHVF) Roche Holding (OTC:RHHBY)"  
[X Link](https://www.benzinga.com/general/biotech/22/04/26907466/roche-releases-more-evrysdi-data-for-very-young-infants-with-sma)  2022-04-29T19:07Z 244.2K followers, [--] engagements


"Roche Unit Spark Therapeutics Hemophilia A Gene Therapy Shows Durable Benefit In Early-Stage Study - Roche Holding (OTC:RHHBF) Roche Holding (OTC:RHHVF) Roche Holding (OTC:RHHBY)"  
[X Link](https://www.benzinga.com/general/biotech/21/02/19515182/roche-unit-spark-therapeutics-hemophilia-a-gene-therapy-shows-durable-benefit-in-early-stage-stud)  2021-02-05T17:37Z 244.2K followers, [--] engagements


"We are pleased to announce positive results from a Phase III cancer #immunotherapy study for the initial treatment of small cell #lungcancer. $ROG $RHHBY http://ow.ly/H0Tg30kE3eR http://ow.ly/H0Tg30kE3eR"  
[X Link](https://x.com/Roche/status/1011172210927718400)  2018-06-25T09:00Z 245.3K followers, [--] engagements


"Roche receives FDA Breakthrough Therapy Designation for the first-line treatment of hepatocellular carcinoma. $ROG $RHHBY #livercancer http://ow.ly/Ic2Y30kYzU9 http://ow.ly/Ic2Y30kYzU9"  
[X Link](https://x.com/Roche/status/1019450466453868546)  2018-07-18T05:15Z 245.2K followers, [---] engagements


"Very strong performance in both divisions: In the first half of [----] sales in the Pharmaceuticals Division rose 7% and Diagnostics Division sales grew 6%. $ROG $RHHBY http://ow.ly/GAGL30l7JN9 http://ow.ly/GAGL30l7JN9"  
[X Link](https://x.com/Roche/status/1022352776578379777)  2018-07-26T05:27Z 245.3K followers, [--] engagements


"In the first half of the year both our Pharmaceuticals and Diagnostics Divisions achieved very strong results. $ROG $RHHBY http://ow.ly/ZUSD30l7YaH http://ow.ly/ZUSD30l7YaH"  
[X Link](https://x.com/Roche/status/1022452724669923329)  2018-07-26T12:05Z 245.3K followers, [--] engagements


"We are presenting cancer #immunotherapy data from a Phase III study in first-line non-squamous non-small cell #lungcancer a form of lung cancer accounting for 85% of cases at #ESMO18. $ROG $RHHBY http://ow.ly/s3Ym30mjAZc http://ow.ly/s3Ym30mjAZc"  
[X Link](https://x.com/Roche/status/1054315213279948802)  2018-10-22T10:15Z 245.3K followers, [--] engagements


"The first antiviral #influenza medicine for [--] years has been approved by the #FDA. This is the only medicine of its kind approved to treat the #flu. $RHHBY $ROG http://ow.ly/JJc130mluta http://ow.ly/JJc130mluta"  
[X Link](https://x.com/Roche/status/1055157056464920579)  2018-10-24T18:00Z 245.3K followers, [--] engagements


"Were pleased to announce new data from phase II #ophthalmology trials of two first-of-their kind medicines in neovascular AMD at #aao2018. #eyehealth $RHHBY $ROG http://ow.ly/Sej330mpmDJ http://ow.ly/Sej330mpmDJ"  
[X Link](https://x.com/Roche/status/1056853197879414784)  2018-10-29T10:20Z 245.3K followers, [--] engagements


"Roche announces phase III study in previously untreated chronic lymphocytic #leukemia met its primary endpoint. $ROG $RHHBY http://ow.ly/KVmH30msiin http://ow.ly/KVmH30msiin"  
[X Link](https://x.com/Roche/status/1058026003979747329)  2018-11-01T16:00Z 245.3K followers, [--] engagements


"We are pleased to announce that the FDA has granted priority review for our cancer #immunotherapy combination for the initial treatment of small cell #lungcancer a disease that has had limited treatment options for the past [--] years. $ROG $RHHBY http://ow.ly/Y7MB30mRZvh http://ow.ly/Y7MB30mRZvh"  
[X Link](https://x.com/Roche/status/1070441483277402114)  2018-12-05T22:15Z 245.4K followers, [--] engagements


"We are pleased to announce that the FDA has granted approval for our #immunotherapy combination in first-line non-squamous non-small cell #lungcancer which accounts for 85% of lung cancer cases. $ROG $RHHBY http://ow.ly/BPST30mTMaj http://ow.ly/BPST30mTMaj"  
[X Link](https://x.com/Roche/status/1070988871935148033)  2018-12-07T10:30Z 245.3K followers, [--] engagements


"Roche is proud to announce that the #EMA has granted PRIME designation for our investigational oral treatment for #spinalmuscularatrophy. $ROG $RHHBY http://ow.ly/mQwj30n0JGx http://ow.ly/mQwj30n0JGx"  
[X Link](https://x.com/Roche/status/1074624026402844672)  2018-12-17T11:15Z 245.4K followers, [--] engagements


"Where there is light there is knowledge: SARS-CoV-2 testing with electrochemiluminescence technology sheds light on antibodies. Learn more: #COVID19 #coronavirus https://go.roche.com/C19AB4 https://go.roche.com/C19AB4"  
[X Link](https://x.com/Roche/status/1257698012798705665)  2020-05-05T15:45Z 245.3K followers, [---] engagements


""It will be a painful process to shift to a more environmentally friendly economy. But that's essentially what we need" says Steve a chemist turned technologist harnessing elements of #sustainability in his approach to #leadership and life 👉 #COVID19 https://bit.ly/36po1KS https://bit.ly/36po1KS"  
[X Link](https://x.com/Roche/status/1314943806345633795)  2020-10-10T15:00Z 245.3K followers, [--] engagements


"Our Roche Nigeria General Manager Dr. Ladi Hameed at #AHAIC2021 sharing insights on Africa's journey to #UHC and exploring how effective #leadership and cross-sector collaboration can advance UHC goals and #health for all Africans #AfricaHealthAgenda #TransformingLives"  
[X Link](https://x.com/Roche/status/1368818776955752453)  2021-03-08T07:00Z 245.3K followers, [--] engagements


"We are pleased to announce the launch of a research use only molecular test to aid in the public health management of emerging #coronavirus #variants. $ROG $RHHBY #Media https://go.roche.com/MR_CV https://go.roche.com/MR_CV"  
[X Link](https://x.com/Roche/status/1371705042546298887)  2021-03-16T06:09Z 245.3K followers, [--] engagements


"Roche launches new high throughput configurations to help increase testing efficiency in high-volume #labs. Available in countries accepting the CE mark. $ROG $RHHBY #media #LabAutomation https://go.roche.com/MR_HTC https://go.roche.com/MR_HTC"  
[X Link](https://x.com/Roche/status/1374241510363860996)  2021-03-23T06:08Z 245.3K followers, [--] engagements


"Were excited to share positive results from a phase III and companion phase II study evaluating the antibody cocktail for #COVID19 in non-hospitalised patients offering hope as a potential new therapy to high-risk patients. More here: $RHHBY $ROG https://bit.ly/3tKLWwt https://bit.ly/3tKLWwt"  
[X Link](https://x.com/Roche/status/1374330086988546048)  2021-03-23T12:00Z 245.3K followers, [--] engagements


"Our CEO Severin Schwan comments on the Groups Half-Year Results: $ROG $RHHBY #RocheFinancialResults https://bit.ly/3rnHm7D https://bit.ly/3rnHm7D"  
[X Link](https://x.com/Roche/status/1418118639140712450)  2021-07-22T08:00Z 245.4K followers, [--] engagements


"Watch our CEO Severin Schwan giving his perspective on the Groups Half-Year Results and thanking the #employees that contributed to such #achievement. $ROG $RHHBY #RocheFinancialResults"  
[X Link](https://x.com/Roche/status/1418194208729354252)  2021-07-22T13:00Z 245.3K followers, [--] engagements


"Over [--] abstracts at #ASH2022 feature our broad haematology portfolio and pipeline reinforcing our commitment to address the needs of people with blood disorders including #HaemophiliaA #lymphoma and #PNH $RHHBY $ROG #RocheInnovation #Media https://www.roche.com/media/releases/med-cor-2022-11-03 https://www.roche.com/media/releases/med-cor-2022-11-03"  
[X Link](https://x.com/Roche/status/1588156549620502530)  2022-11-03T13:10Z 245.3K followers, [--] engagements


"The first phase III results from our study in #PNH an ultra-rare life-threatening disease of the blood are being presented at #ASH22 $RHHBY $ROG #RocheInnovation https://www.roche.com/media/releases/med-cor-2022-12-11 https://www.roche.com/media/releases/med-cor-2022-12-11"  
[X Link](https://x.com/Roche/status/1601819075126206465)  2022-12-11T06:00Z 245.3K followers, [--] engagements


"Were pleased to present interim results at #ASH22 from a phase III study in infants with severe #Haemophilia A without factor VIII inhibitors $RHHBY $ROG #RocheInnovation https://www.roche.com/media/releases/med-cor-2022-12-11b https://www.roche.com/media/releases/med-cor-2022-12-11b"  
[X Link](https://x.com/Roche/status/1601819577196896258)  2022-12-11T06:02Z 245.3K followers, [--] engagements


"We are pleased to present updated results in diffuse large B-cell lymphoma at #ASH22 an area where there has been little progress in the first-line setting for the last [--] years $RHHBY $ROG #RocheInnovation #lymsm https://www.roche.com/media/releases/med-cor-2022-12-12b https://www.roche.com/media/releases/med-cor-2022-12-12b"  
[X Link](https://x.com/Roche/status/1602181964945055744)  2022-12-12T06:02Z 245.3K followers, [--] engagements


"Over the weekend at #ASH22 we presented data demonstrating the potential benefit of a new type of cancer immunotherapy in improving outcomes for difficult-to-treat #lymphomas $RHHBY $ROG #RocheInnovation #lymsm https://www.roche.com/media/releases/med-cor-2022-12-12c https://www.roche.com/media/releases/med-cor-2022-12-12c"  
[X Link](https://x.com/Roche/status/1602362653577547779)  2022-12-12T18:00Z 245.3K followers, [--] engagements


"We are pleased that the U.S. FDA has approved our first-in-class cancer immunotherapy for people with relapsed or refractory follicular lymphoma who have had limited treatment options until now. $RHHBY $ROG #RocheInnovation #Science http://spkl.io/60174ZpeR http://spkl.io/60174ZpeR"  
[X Link](https://x.com/Roche/status/1606643360168566785)  2022-12-24T13:30Z 245.3K followers, [----] engagements


"#MEDIA: We are pleased to announce that for the first time in a Phase III clinical trial our cancer immunotherapy reduced the risk of cancer returning in people with certain types of early-stage #LiverCancer Read more 👉 $ROG $RHHBY http://spkl.io/60124wRMM http://spkl.io/60124wRMM"  
[X Link](https://x.com/Roche/status/1616020450827534336)  2023-01-19T10:31Z 245.3K followers, [----] engagements


"#MEDIA - we are pleased to announce the launch of our new PCR test for researchers that detects and differentiates the latest #COVID19 variant of concern XBB [---]. $ROG $RHHBY http://spkl.io/60174wgYx http://spkl.io/60174wgYx"  
[X Link](https://x.com/Roche/status/1618530385255596033)  2023-01-26T08:44Z 245.3K followers, [----] engagements


"Roche offers to acquire all outstanding shares of Illumina Inc. to further strengthen its leading role in diagnostics http://t.co/qOvbG9Hd http://cot.ag/xeniI9 http://cot.ag/xeniI9"  
[X Link](https://x.com/Roche/status/162055069909516288)  2012-01-25T06:11Z 245.2K followers, [--] engagements


"Discover how our teams made an impact in [----] while tackling some of the worlds biggest health challenges. For insights into our purpose-led journey head here ➡ $ROG $RHHBY https://go.roche.com/AnnualReportMR https://go.roche.com/AnnualReportMR"  
[X Link](https://x.com/Roche/status/1621035464646877185)  2023-02-02T06:39Z 245.3K followers, 11K engagements


"By putting science at the heart of Roche our ambition is to help people do more feel better live longer. Learn more about how our teams made an impact in [----] ➡ $ROG $RHHBY https://go.roche.com/AnnualReport https://go.roche.com/AnnualReport"  
[X Link](https://x.com/Roche/status/1621086029422764033)  2023-02-02T10:00Z 245.3K followers, [----] engagements


"Roche commences tender offer for Illumina Inc. for $44.50 per share in cash http://t.co/qYFdB7Zr #RocheIR #ngs http://cot.ag/wfMPcM http://cot.ag/wfMPcM"  
[X Link](https://x.com/Roche/status/162944828127191040)  2012-01-27T17:07Z 245.3K followers, [--] engagements


"Roche to nominate slate of independent directors for election at Illumina Inc.s [----] annual meeting http://t.co/GNkwrurQ http://cot.ag/z1j1PJ http://cot.ag/z1j1PJ"  
[X Link](https://x.com/Roche/status/164393227938578434)  2012-01-31T17:02Z 245.3K followers, [--] engagements


"Were pleased to announce that the EC has approved our fixed-duration off-the-shelf cancer immunotherapy for patients with relapsed or refractory diffuse large B-cell #lymphoma the first therapy of its kind in Europe. $ROG #RocheInnovation #Science"  
[X Link](https://x.com/Roche/status/1678677345706680321)  2023-07-12T06:18Z 246.8K followers, [----] engagements


"The Roche Groups passion for innovation is as important as our passion for improving healthcare for all. We provide all the tools to allow our researchers to follow their scientific passions and keep making breakthroughs. Find out more here:"  
[X Link](https://x.com/Roche/status/1696779792861786437)  2023-08-30T07:00Z 246.9K followers, [----] engagements


"Today we will be participating in 'Making the Right decision for Me' in Milan. The panel discussion will present perspectives from both healthcare professionals and the #MS community. Follow this thread and learn more about this topic #ECTRIMS2023"  
[X Link](https://x.com/Roche/status/1712138635758252478)  2023-10-11T16:10Z 245.3K followers, [----] engagements


"The panel discussion will feature perspectives from both HCPs and the #MS community to generate an open dialogue on the current challenges and opportunities in shared decision making and the value of effective communication in determining the best approach to disease management"  
[X Link](https://x.com/Roche/status/1712138638245396870)  2023-10-11T16:10Z 246.8K followers, [----] engagements


"🧬Exciting news: Together for CHANGE initiative launched Roche joins forces with Meharry Medical College Regeneron AstraZeneca & Novo Nordisk to build the largest genomics research database of African ancestry. Learn more 👉"  
[X Link](https://x.com/Roche/status/1714651456400507227)  2023-10-18T14:35Z 246.9K followers, [----] engagements


"📢 Roche reports good sales growth despite decline in demand for COVID-19 products 👉 Read the full media release here: $ROG $RHHBY #RocheFinancialResults http://spkl.io/60104W01e http://spkl.io/60104W01e"  
[X Link](https://x.com/Roche/status/1714871587248230718)  2023-10-19T05:10Z 245.2K followers, [----] engagements


"We are pleased to announce the acquisition of Telavant providing us rights to a novel TL1A directed antibody a promising new therapy for people suffering from inflammatory bowel disease and potentially multiple other diseases. $ROG $RHHBY Read more:"  
[X Link](https://x.com/anyuser/status/1716322093925544369)  2023-10-23T05:14Z [--] followers, [----] engagements


"#WorldCOPDDay is November 15th and from now until then we want to show you how important it is to #SpeakUpforCOPD. Lets start this journey by explaining what COPD is"  
[X Link](https://x.com/Roche/status/1720712498293227728)  2023-11-04T08:00Z 246K followers, [----] engagements


"On our journey to mark #WorldCOPDDay its vital that we know how impactful #COPD is worldwide. Take a look at these three stats to understand the importance of #SpeakUpforCOPD"  
[X Link](https://x.com/Roche/status/1722630138918244686)  2023-11-09T15:00Z 246K followers, [----] engagements


"Although #COPD is the third leading cause of death worldwide there is still an urgent need for greater recognition of the impact of COPD on individuals and society to ensure people living with this disease receive the care they need and deserve"  
[X Link](https://x.com/Roche/status/1724049481274937353)  2023-11-13T13:00Z 246K followers, [----] engagements


"@CharlyMon7 Hi Charlie. Could you send us a Direct message to ask you some questions and attend to your case Ana on behalf of the Roche Social Media team"  
[X Link](https://x.com/Roche/status/1727370045930836427)  2023-11-22T16:54Z 246.9K followers, [--] engagements


"#MEDIA We are pleased to announce that our immunoassay to determine the presence and quantity of the #hepatitis B e antigen in human serum and plasma has received CE approval. Learn more here 👉 $ROG $RHHBY"  
[X Link](https://x.com/Roche/status/1729063774294786274)  2023-11-27T09:05Z 246.9K followers, [----] engagements


"@san01992367 You can also contact our local Drug Safety Centre whose details are available here: Wishing you all the very best. Ana on behalf of the Roche Social Media team"  
[X Link](https://x.com/Roche/status/1729130887420191049)  2023-11-27T13:31Z 246.8K followers, [--] engagements


"Tune in to the first episode of the SMA My Way podcast - spotlighting Spinal Muscular Atrophy (SMA) on #DisabilityDay. Let's elevate the dialogue together. #IDPD"  
[X Link](https://x.com/Roche/status/1731236870770639099)  2023-12-03T09:00Z 246.8K followers, [----] engagements


"@AdeoyeAdemolaA1 Hi Abel Please find my reply in your DMs. Wishing you all the very best Kriszta on behalf of the Roche Social Media team"  
[X Link](https://x.com/anyuser/status/1739942075892744403)  2023-12-27T09:31Z [--] followers, [--] engagements


"For [--] years our partnership has delivered innovative diagnostic solutions enhancing patient care globally. Excited for the future #Partnership #Diagnostics #Innovation http://spkl.io/60104fJnE http://spkl.io/60104fJnE"  
[X Link](https://x.com/Roche/status/1796466661723156494)  2024-05-31T09:00Z 246.1K followers, [----] engagements


"#MEDIA Today at the #2024SMAConference we share 5-year data from the #FIREFISH study in children with Spinal Muscular Atrophy. Thank you to the children families and all involved who have contributed to our understanding of #SMA. @CureSMA $ROG $RHHBY http://spkl.io/60164fQ8n http://spkl.io/60164fQ8n"  
[X Link](https://x.com/Roche/status/1799094280427844078)  2024-06-07T15:01Z 245.8K followers, [----] engagements


"#MEDIA We are pleased to announce that our four-in-one combination molecular test for #SARSCoV2 #Influenza A/B viruses and #RSV has received U.S. FDA Emergency Use Authorization. Learn more: $ROG $RHHBY http://spkl.io/60144f2Vo http://spkl.io/60144f2Vo"  
[X Link](https://x.com/Roche/status/1800060336042598783)  2024-06-10T07:00Z 245.8K followers, [----] engagements


"The European Commission has delivered a landmark approval for our ALK inhibitor in resected ALK-positive lung cancer with the potential to address an urgent unmet need and bring an important new treatment option to many more patients. $RHHBY $ROG http://spkl.io/60174f2aW http://spkl.io/60174f2aW"  
[X Link](https://x.com/Roche/status/1800091254237094206)  2024-06-10T09:02Z 245.8K followers, [----] engagements


"One walk countless smiles. The Roche Children's Walk starts on June 11th uniting colleagues globally to support children's education. Together we're making a difference in #Malawi #Ethiopia #Cambodia and more. Join us: #RochePhilanthropy http://spkl.io/60154fCoW http://spkl.io/60154fCoW"  
[X Link](https://x.com/Roche/status/1800505774306693284)  2024-06-11T12:30Z 246.1K followers, [----] engagements


"#MEDIA - We are pleased to announce the launch of our highly-sensitive Kappa and Lambda multiplex test to more easily diagnose patients that may have B-cell #lymphoma. Learn more: $ROG $RHHBY http://spkl.io/60114AcbX http://spkl.io/60114AcbX"  
[X Link](https://x.com/Roche/status/1803701830112661944)  2024-06-20T08:10Z 245.8K followers, [----] engagements


"#MEDIA We are pleased to announce the launch of two new analytical units which will deliver greater efficiency and capacity to #laboratories in CE mark countries. Learn more here: $ROG $RHHBY http://spkl.io/60104AIcu http://spkl.io/60104AIcu"  
[X Link](https://x.com/Roche/status/1805229397667951035)  2024-06-24T13:20Z 245.8K followers, [----] engagements


"#MEDIA - We are pleased to announce that @WHO has awarded prequalification to all of our #HPV screening solutions allowing governments to expand national screening programs that help prevent #cervicalcancer. Learn more: $ROG $RHHBY http://spkl.io/6018478E6 http://spkl.io/6018478E6"  
[X Link](https://x.com/Roche/status/1806232255322370297)  2024-06-27T07:45Z 245.8K followers, [----] engagements


"#MEDIA We are pleased to announce that the CHMP has recommended EU approval of our treatment for #ParoxysmalNocturnalHaemoglobinuria - a rare life-threatening blood condition. Learn more here: $ROG $RHHBY http://spkl.io/601947H9D http://spkl.io/601947H9D"  
[X Link](https://x.com/Roche/status/1806660483967033512)  2024-06-28T12:06Z 245.8K followers, [----] engagements


"#MEDIA The #CHMP has issued a positive recommendation for our bispecific antibody for the treatment of macular edema due to RVO furthering our mission to save peoples sight from the leading causes of #VisionLoss. $ROG $RHHBY http://spkl.io/601647HYi http://spkl.io/601647HYi"  
[X Link](https://x.com/Roche/status/1806673916896698518)  2024-06-28T13:00Z 245.8K followers, [----] engagements


"#MEDIA We are happy to announce that the U.S. FDA has approved the single-dose pre-filled syringe of the first and only bispecific antibody to treat three leading causes of #VisionLoss - nAMD DME and RVO. $ROG $RHHBY http://spkl.io/6017479uV http://spkl.io/6017479uV"  
[X Link](https://x.com/Roche/status/1809154790791761976)  2024-07-05T09:18Z 245.9K followers, [----] engagements


"#MEDIA We are pleased to announce the reintroduction of our refillable eye implant in the US for the treatment of nAMD the leading cause of #VisionLoss in people over the age of [--]. $ROG $RHHBY http://spkl.io/601247tPo http://spkl.io/601247tPo"  
[X Link](https://x.com/Roche/status/1810410908671221774)  2024-07-08T20:29Z 245.8K followers, [----] engagements


"#MEDIA Were happy to announce late-breaking data at #ASRS2024 from the long-term study of our bispecific antibody for the treatment of DME - welcome news for the millions of people at risk of #VisionLoss. $ROG $RHHBY http://spkl.io/60194CrS5 http://spkl.io/60194CrS5"  
[X Link](https://x.com/Roche/status/1813606360220590219)  2024-07-17T16:07Z 245.9K followers, [----] engagements


"#MEDIA Were proud to present new two-year data on two serious diabetic eye conditions for our refillable eye implant at #ASRS2024. Additionally the US FDA has accepted our application for the potential approval of the implant in these conditions. $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2024-07-18 https://www.roche.com/media/releases/med-cor-2024-07-18 https://www.roche.com/media/releases/med-cor-2024-07-18 https://www.roche.com/media/releases/med-cor-2024-07-18"  
[X Link](https://x.com/Roche/status/1813914525768327293)  2024-07-18T12:31Z 245.9K followers, [----] engagements


"We are pleased to announce today the completion of the acquisition of @LumiraDxs Point of Care diagnostics technology enabling us to expand patient access to timely diagnostics results in decentralised healthcare settings worldwide. $ROG $RHHBY ➡ http://spkl.io/60164CC6G http://spkl.io/60164CC6G"  
[X Link](https://x.com/Roche/status/1817795354697294035)  2024-07-29T05:32Z 245.9K followers, [----] engagements


"#MEDIA Our bispecific antibody has received approval from the European Commission for the treatment of macular edema secondary to retinal vein occlusion (RVO)furthering our mission to save peoples sight from the leading causes of #VisionLoss. $ROG $RHHBY http://spkl.io/60114h8iv http://spkl.io/60114h8iv"  
[X Link](https://x.com/Roche/status/1818206189869482199)  2024-07-30T08:45Z 245.9K followers, [----] engagements


"#MEDIA We are supporting @WHO declaration of a global health emergency due to the ongoing #mpox outbreak with diagnostic tests developed for mpox formerly known as #monkeypox. Learn more: $ROG $RHHBY http://spkl.io/6018f6pRy http://spkl.io/6018f6pRy"  
[X Link](https://x.com/Roche/status/1825881317982015777)  2024-08-20T13:03Z 245.4K followers, [----] engagements


"#MEDIA We are pleased to announce that the European Commission has approved our treatment for paroxysmal nocturnal haemoglobinuria in the EU. Learn more: $ROG $RHHBY #PNH http://spkl.io/6012f6xoo http://spkl.io/6012f6xoo"  
[X Link](https://x.com/Roche/status/1828364434256842784)  2024-08-27T09:30Z 245.3K followers, [----] engagements


"Roche and SAS Brasil are joining forces to provide holistic solutions and better cervical cancer outcomes for women in Brazil. Learn more #TogetherForChange #Partnerships #XProject http://spkl.io/6013fBdt3 http://spkl.io/6013fBdt3"  
[X Link](https://x.com/Roche/status/1831225741599470027)  2024-09-04T07:00Z 245.3K followers, [----] engagements


"#MEDIA We are proud to announce the inauguration of the Roche pRED Innovation Centre in Basel. This new cutting-edge facility is ready to lead the way in medical research and innovation and deliver meaningful impact to patients. Learn more here: http://spkl.io/6015f8Hkv http://spkl.io/6015f8Hkv"  
[X Link](https://x.com/Roche/status/1833732206096756817)  2024-09-11T05:00Z 245.3K followers, [----] engagements


"#MEDIA The FDA approved the subcutaneous injection of our #cancer immunotherapy for certain lung liver skin and soft tissue cancer types. This approval is part of our commitment to offering patients and healthcare providers more options. $RHHBY $ROG http://spkl.io/6011f8XQ1 http://spkl.io/6011f8XQ1"  
[X Link](https://x.com/Roche/status/1834533491435872468)  2024-09-13T10:04Z 244.1K followers, [----] engagements


"#MEDIA- We are pleased to announce that our #antiviral showed a significant reduction in the transmission of #influenza from an individual with the infection to household members in a Phase III study. $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2024-09-19 https://www.roche.com/media/releases/med-cor-2024-09-19"  
[X Link](https://x.com/Roche/status/1836662224703594755)  2024-09-19T07:02Z 244.1K followers, [----] engagements


"#MEDIA We are pleased to announce our first test to use breakthrough technology that can detect [--] respiratory viruses simultaneously on our high throughput analysers. Learn more: $ROG $RHHBY http://spkl.io/6015fJizJ http://spkl.io/6015fJizJ"  
[X Link](https://x.com/Roche/status/1838497610048376964)  2024-09-24T08:36Z 244.1K followers, [----] engagements


"#MEDIA We are excited to announce first data from a phase III study in people with active #LupusNephritis. This study reflects our ongoing commitment to people living with kidney and kidney-related diseases. $ROG $RHHBY http://spkl.io/6015fJxp5 http://spkl.io/6015fJxp5"  
[X Link](https://x.com/Roche/status/1839211215429439743)  2024-09-26T07:51Z 244.1K followers, [----] engagements


"How to create a lasting impact on Kenya's breast cancer care Learn more barriers through #TogetherForChange #Partnerships #XProject http://spkl.io/6015fBHi1 http://spkl.io/6015fBHi1"  
[X Link](https://x.com/Roche/status/1841463184810537043)  2024-10-02T13:00Z 244K followers, [----] engagements


"#MEDIA - We are pleased to announce the first companion diagnostic test to receive CE Mark approval for determining CLDN18 protein expression in tumours of patients with gastric or gastroesophageal junction (GEJ) #cancer. Learn more: $ROG $RHHBY http://spkl.io/6016fPd3y http://spkl.io/6016fPd3y"  
[X Link](https://x.com/Roche/status/1844284237555339463)  2024-10-10T07:50Z 244.2K followers, [----] engagements


"#MEDIA The FDA has approved our medicine for advanced HR-positive HER2-negative #BreastCancer with a PIK3CA mutation one of the most commonly mutated genes in HR-positive disease associated with poor prognosis. $ROG $RHHBY http://spkl.io/6013fPIsx http://spkl.io/6013fPIsx"  
[X Link](https://x.com/Roche/status/1844724955264536903)  2024-10-11T13:01Z 244.2K followers, [----] engagements


"#MEDIA We are pleased to announce data from a first-of-its-kind phase IV study in historically underrepresented people with diabetic macular edema reflecting our commitment to diverse and inclusive research. $ROG $RHHBY http://spkl.io/6017fROF9 http://spkl.io/6017fROF9"  
[X Link](https://x.com/Roche/status/1847386909120876822)  2024-10-18T21:18Z 244K followers, [----] engagements


"📢 Roches strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months 👉 Read the full media release here: $ROG $RHHBY #RocheFinancialResults #earnings http://spkl.io/6011fRUUD http://spkl.io/6011fRUUD"  
[X Link](https://x.com/Roche/status/1848955015035002929)  2024-10-23T05:10Z 243.8K followers, [----] engagements


"🚀We are delighted to see three of our innovation engines on the prestigious @ScienceCareers [----] Top Employers list🔝 We would like to thank all the teams who made this achievement possible. Were more motivated than ever to tackle the challenges that lie ahead💪 Read more about it here: http://spkl.io/6042fRCSk Congratulations to Insmed @Regeneron @Incyte @VertexPharma @Syngenta @spark_tx @Alnylam @Roche @Bioconlimited and @genentech for making it to the top [--] in the Top Employers' rankings #SCTopEmployers 👉View the full article online: https://t.co/ChumK795HU https://t.co/1zvNy4wbF2"  
[X Link](https://x.com/Roche/status/1849716016772706581)  2024-10-25T07:33Z 244.3K followers, [----] engagements


"#MEDIA - We are pleased that phase III data for our medicine for people with advanced PIK3CA-mutated HR-positive HER2-negative breast cancer have been published in the New England Journal of Medicine. Find out more on $ROG $RHHBY http://spkl.io/6016frL10 http://spkl.io/6016frL10"  
[X Link](https://x.com/Roche/status/1851935065258758388)  2024-10-31T10:31Z 243.8K followers, [----] engagements


"#MEDIA - we are pleased to present new data at the 17th Clinical Trials in Alzheimers Disease congress (CTAD) demonstrating our growing momentum in diagnostics for Alzheimers disease. Learn more: $ROG $RHHBY #Alzheimers http://spkl.io/6011frFbN http://spkl.io/6011frFbN"  
[X Link](https://x.com/Roche/status/1851984983344230653)  2024-10-31T13:50Z 243.8K followers, [----] engagements


"The power of partnerships can transform healthcare. Through collaboration we're paving the way in fighting breast cancer in Algeria. Learn more #TogetherForChange #Partnerships #XProject Find out more on: http://spkl.io/6012frXWn http://spkl.io/6012frXWn"  
[X Link](https://x.com/Roche/status/1852606615737798959)  2024-11-02T07:00Z 245.1K followers, [----] engagements


"Not sure how to transform your workspace into a more diabetes-friendly environment Shelley and other Roche colleagues living with #diabetes share tips on how to be more inclusive. Find out more: #ConnectingWhatCounts #WorldDiabetesDay http://spkl.io/6011fTWU1 http://spkl.io/6011fTWU1"  
[X Link](https://x.com/Roche/status/1854142140730703953)  2024-11-06T12:41Z 244.5K followers, [----] engagements


"At Roche we are committed to innovation developing pioneering medicines to deliver substantial patient benefits. Today we are excited to announce that we entered into a definitive agreement to acquire @PoseidaThera . This acquisition will enhance our combined expertise unlock new possibilities and pave the way for first-in-class therapies across various indications. #RocheInnovation #Celltherapy #Oncology $ROG $RHHBY Read more: https://www.roche.com/media/releases/med-cor-2024-11-26b https://www.roche.com/media/releases/med-cor-2024-11-26b"  
[X Link](https://x.com/Roche/status/1861294980276387961)  2024-11-26T06:24Z 244.1K followers, [----] engagements


"#MEDIA We are pleased the U.S. FDA has accepted our supplementary Biologics License Application for our bispecific antibody combination offering a potential off-the-shelf treatment for an aggressive form of #lymphoma. ➡ $RHHBY $ROG http://spkl.io/6010fZzKC http://spkl.io/6010fZzKC"  
[X Link](https://x.com/Roche/status/1864610138700521636)  2024-12-05T09:57Z 243.7K followers, [----] engagements


"#MEDIA We are pleased to present five-year follow-up data on our combination treatment at #ASH24 the first to advance the standard of care in frontline diffuse large B-cell #lymphoma in [--] years ➡ $RHHBY $ROG http://spkl.io/6012fZ4pn http://spkl.io/6012fZ4pn"  
[X Link](https://x.com/Roche/status/1866071211681226952)  2024-12-09T10:43Z 243.7K followers, [----] engagements


"#MEDIA We are presenting new and long-term follow-up data on our fixed-duration bispecific antibodies at #ASH24 reinforcing their potential to advance outcomes for people living with advanced #lymphomas. ➡ $RHHBY $ROG http://spkl.io/6010fwJYA http://spkl.io/6010fwJYA"  
[X Link](https://x.com/Roche/status/1866437707213209615)  2024-12-10T11:00Z 243.7K followers, [----] engagements


"#MEDIA - Roche is pleased to announce the CE Mark for the new and updated molecular cobas 6800/8800 systems [---] enhancing laboratory efficiency and testing capabilities. #ValueOfDiagnostics #RocheInnovation $ROG $RHHBY http://spkl.io/6015fwxdH http://spkl.io/6015fwxdH"  
[X Link](https://x.com/Roche/status/1867460000836149605)  2024-12-13T06:42Z 243.7K followers, [----] engagements


"#MEDIA - We are pleased to announce the launch of our new solution to transform clinical mass spectrometry. Learn more: #massspectrometry #innovation #diagnostics #RocheMassSpec $ROG $RHHBY http://spkl.io/6015fbaHl http://spkl.io/6015fbaHl"  
[X Link](https://x.com/Roche/status/1869264845490536575)  2024-12-18T06:14Z 244.1K followers, [--] engagements


"#MEDIA - We are pleased to announce the launch of our new solution to transform clinical mass spectrometry. Learn more: #massspectrometry #innovation #diagnostics #RocheMassSpec $ROG $RHHBY https://go.roche.com/MassSpecMediaRelease https://go.roche.com/MassSpecMediaRelease"  
[X Link](https://x.com/Roche/status/1869268761728917642)  2024-12-18T06:29Z 243.7K followers, [----] engagements


"At Roche we are going beyond what was thought possible in diagnostics. Backed by science and led by #innovation we are pushing boundaries today to advance the #healthcare of tomorrow. In labs for patients for the world. #RocheMassSpec https://go.roche.com/MassSpecX https://go.roche.com/MassSpecX"  
[X Link](https://x.com/Roche/status/1870605184931385724)  2024-12-21T23:00Z 244K followers, [----] engagements


"#MEDIA We are pleased to announce that our molecular tests to diagnose sexually transmitted infections at the point of care have received FDA clearance with CLIA waiver in the U.S. Learn more here: $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2025-01-22 https://www.roche.com/media/releases/med-cor-2025-01-22"  
[X Link](https://x.com/Roche/status/1881946155187155093)  2025-01-22T06:05Z 243K followers, [----] engagements


"Roche reports strong [----] results with 7% (CER) sales growth; fourth quarter marks third straight quarter of 9% growth. 👉 Read the full release here: $ROG $RHHBY #FinancialResults https://spkl.io/6012fc0TK https://spkl.io/6012fc0TK"  
[X Link](https://x.com/Roche/status/1884847359592456700)  2025-01-30T06:13Z 242.1K followers, 12.1K engagements


"#MEDIA Roche is pleased to share positive results showing our medicine has demonstrated a significant overall survival benefit for those living with advanced PIK3CA-mutated HR-positive HER2-negative #BreastCancer $ROG $RHHBY https://spkl.io/6015fcCYb https://spkl.io/6015fcCYb"  
[X Link](https://x.com/Roche/status/1884994815940538773)  2025-01-30T15:59Z 242.1K followers, [----] engagements


"#MEDIA - We are pleased to announce FDA approval for first companion #diagnostic to identify metastatic breast cancer patients with ultralow #HER2 expression eligible for a targeted treatment option. Learn more: #PrecisionMedicine $ROG $RHHBY https://spkl.io/6010fY3T4 https://spkl.io/6010fY3T4"  
[X Link](https://x.com/Roche/status/1885375991385645166)  2025-01-31T17:13Z 242.1K followers, [----] engagements


"#MEDIA We are delighted to announce that the US FDA has approved our refillable eye implant to treat a leading cause of #VisionLoss in adults with diabetes diabetic macular edema (DME). $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2025-02-04 https://www.roche.com/media/releases/med-cor-2025-02-04"  
[X Link](https://x.com/Roche/status/1886821027545575778)  2025-02-04T16:56Z 242K followers, [----] engagements


"#MEDIA We are pleased to share full data from our Phase III study in #LupusNephritis being presented today at the @ISNWCN and published in the @NEJM. This study reflects our commitment to advancing the treatment of kidney diseases. $ROG $RHHBY https://spkl.io/6010fl9us https://spkl.io/6010fl9us"  
[X Link](https://x.com/Roche/status/1887849198453702977)  2025-02-07T13:01Z 242.1K followers, [----] engagements


"#MEDIA We are pleased the CHMP has recommended EU approval of our off-the-shelf bispecific antibody combination offering a treatment that could be immediately available following relapse for people with an aggressive form of #lymphoma. $RHHBY $ROG https://spkl.io/6015fUb45 https://spkl.io/6015fUb45"  
[X Link](https://x.com/Roche/status/1895485002323726600)  2025-02-28T14:43Z 242.1K followers, [----] engagements


"We are thrilled to celebrate our member company Chugai Pharmaceuticals 100th anniversary today Our alliance has brought benefits to patients worldwide. Here's to [---] more years of innovation 🎉 Learn more at: #Chugai100thAniversary #Roche https://spkl.io/6015fS1yW https://spkl.io/6015fS1yW"  
[X Link](https://x.com/Roche/status/1898931825826725971)  2025-03-10T03:00Z 242.9K followers, [----] engagements


"#MEDIA We are pleased the EC has approved our first-of-a-kind bispecific antibody combination for an aggressive form of #lymphoma offering an off-the-shelf option for patients whose cancer returns or doesnt respond to initial treatment. $RHHBY $ROG https://spkl.io/6016fx6sp https://spkl.io/6016fx6sp"  
[X Link](https://x.com/Roche/status/1911698450967650798)  2025-04-14T08:30Z 241.9K followers, [----] engagements


"Roche continues good momentum into [----] with a 6% (CER) sales growth in the first quarter. For more details on our performance click here ➡ $ROG $RHHBY #FinancialResults https://spkl.io/6011fI9Wt https://spkl.io/6011fI9Wt"  
[X Link](https://x.com/Roche/status/1915272429326188833)  2025-04-24T05:11Z 240.9K followers, [----] engagements


"#MEDIA - We are pleased to share that our Phase III study results published in @NEJM show a significant reduction in #influenza transmission from infected individuals to household members. $ROG $RHHBY https://spkl.io/6011fItbB https://spkl.io/6011fItbB"  
[X Link](https://x.com/Roche/status/1915675986944835722)  2025-04-25T07:55Z 240.9K followers, [----] engagements


"#MEDIA We are pleased the CHMP has recommended our medicine for HER2 - positive #BreastCancer can be given outside of the clinic (at home) helping to alleviate the burden of treatment on peoples lives and freeing up cancer care capacity. $ROG $RHHBY https://spkl.io/6019fLbmz https://spkl.io/6019fLbmz"  
[X Link](https://x.com/Roche/status/1917481606849188217)  2025-04-30T07:30Z 240.9K followers, [----] engagements


"#MEDIA We are pleased to be presenting new ten-year data for our medicine in HER2-positive #BreastCancer at #ESMOBreast25 today. These data reflect our continued commitment to addressing unmet needs for people diagnosed with breast cancer. $ROG $RHHBY https://spkl.io/6013fFdUZ https://spkl.io/6013fFdUZ"  
[X Link](https://x.com/Roche/status/1922181311919259857)  2025-05-13T06:45Z 240.9K followers, [----] engagements


"@BusinessatOECD @G7 @CdnChamberofCom @ISED_CA @innovativemeds @adMare_Bio @sanofi @KamalKheraLib @orencsak @canadabusiness @GovCanHealth @OECDglobal @FranColombo2019 @OECD_Social @DavidElviraM @GCMcCauley @G7Canada Looking forward to a crucial discussion on #HealthSecurity & #EconomicSecurity at next week's #B7 Summit . #G7"  
[X Link](https://x.com/Roche/status/1922354335691809177)  2025-05-13T18:12Z 240.9K followers, [---] engagements


"@BusinessatOECD @G7 @CdnChamberofCom @innovativemeds @adMare_Bio @sanofi @OECD @IFPMA @DavidReddyIFPMA @orencsak @GCMcCauley @DavidElviraM @FranColombo2019 @OECD_Social @ISED_CA @canadabusiness @G7Canada Thanks @CdnChamberofCom for convening a powerful discussion at the #B7Summit. We were glad to stand alongside partners calling for prevention digital innovation and investment to reinforce economic and health resilience. #G7"  
[X Link](https://x.com/Roche/status/1924540222299111898)  2025-05-19T18:58Z 240.9K followers, [---] engagements


"#MEDIA We are happy to announce that the US FDA has approved our refillable eye implant for its third indication diabetic retinopathy (DR) - a leading cause of #VisionLoss in adults with diabetes. $ROG $RHHBY https://www.roche.com/media/releases/med-cor-2025-05-22 https://www.roche.com/media/releases/med-cor-2025-05-22"  
[X Link](https://x.com/Roche/status/1925583093718470988)  2025-05-22T16:02Z 240.9K followers, [----] engagements


"#MEDIA We are pleased to announce new two-year follow-up data at #ASCO25 showing an extended survival benefit with our off-the-shelf bispecific antibody combination for people with an aggressive form of #lymphoma after initial relapse. $RHHBY $ROG https://spkl.io/6010fNuCI https://spkl.io/6010fNuCI"  
[X Link](https://x.com/Roche/status/1925909594582184141)  2025-05-23T13:40Z 241K followers, [----] engagements


"#MEDIA We are pleased to announce a positive CHMP opinion for our medicine in advanced PIK3CA-mutated ER-positive HER2-negative #BreastCancer an aggressive subtype of breast cancer associated with a poor prognosis. $ROG $RHHBY https://spkl.io/6019fNTNv https://spkl.io/6019fNTNv"  
[X Link](https://x.com/Roche/status/1925932241475043446)  2025-05-23T15:10Z 241K followers, [----] engagements


"#MEDIA New 96-week data shows maintained near-complete suppression of disease activity and no disability progression for up to two years in people with relapsing multiple sclerosis. #MultipleSclerosis #ClinicalTrials $ROG $RHHBY https://spkl.io/6014ffUv2 https://spkl.io/6014ffUv2"  
[X Link](https://x.com/Roche/status/1928348445514875259)  2025-05-30T07:11Z 241K followers, [----] engagements


"#MEDIA We are pleased to be presenting new overall survival data at #ASCO25 for our medicine in people with advanced PIK3CA-mutated HR-positive HER2-negative #BreastCancer supporting standard of care potential. $ROG $RHHBY https://spkl.io/6018ffNsm https://spkl.io/6018ffNsm"  
[X Link](https://x.com/Roche/status/1928798174841340305)  2025-05-31T12:58Z 241K followers, [----] engagements


"#MEDIA We are very encouraged about the Phase III data being presented at #ASCO25 by @Alliance_org in #coloncancer. Huge thanks to Alliance the investigators and patients taking part in this study. $ROG $RHHBY"  
[X Link](https://x.com/Roche/status/1929240287144022046)  2025-06-01T18:15Z 241K followers, [----] engagements


"#MEDIA We are pleased our Phase III data at #ASCO25 published in #TheLancet show survival benefits for people with small cell #lungcancer. SCLC is an aggressive cancer type where more options for disease control are highly needed: $ROG $RHHBY https://spkl.io/6016fAn54 https://spkl.io/6016fAn54"  
[X Link](https://x.com/Roche/status/1929818481710547076)  2025-06-03T08:32Z 241K followers, [----] engagements


"#MEDIA We are advancing our investigational anti-alpha-synuclein antibody into Phase III development for early-stage #ParkinsonsDisease $ROG $RHHBY https://spkl.io/6016fC0xi https://spkl.io/6016fC0xi"  
[X Link](https://x.com/Roche/status/1934532973354692711)  2025-06-16T08:46Z 240.8K followers, [----] engagements


"Pharma and academia play distinct but complementary roles in driving innovation. In a new @Nature article @HansClevers shares insights on how bridging both worlds can accelerate progress in healthcare. Read more here: https://spkl.io/6010fhJIC https://spkl.io/6010fhJIC"  
[X Link](https://x.com/Roche/status/1935819893519094054)  2025-06-19T22:00Z 241K followers, [----] engagements


"#MEDIA We're pleased to share new late-breaking data at #18ICML showing that our investigational combination treatment could offer people with aggressive #lymphoma a well-tolerated option without traditional chemotherapy. $RHHBY $ROG https://spkl.io/6010fh0JC https://spkl.io/6010fh0JC"  
[X Link](https://x.com/Roche/status/1936091681318744194)  2025-06-20T16:00Z 240.9K followers, [----] engagements


"#MEDIA - Were pleased to announce we have received CE mark for our blood test to rule out Alzheimers disease. This minimally invasive test can reduce the need for additional confirmatory investigations. $RHHBY $ROG http://www.roche.com/media http://www.roche.com/media"  
[X Link](https://x.com/Roche/status/1947891929267527781)  2025-07-23T05:30Z 240.8K followers, [----] engagements


"#MEDIA We are pleased to announce that the European Commission has approved our medicine for PIK3CA-mutated ER-positive HER2-negative advanced #BreastCancer helping to address an urgent unmet need. $ROG $RHHBY https://go.roche.com/eucom https://go.roche.com/eucom"  
[X Link](https://x.com/Roche/status/1947974977040396462)  2025-07-23T11:00Z 240.7K followers, [----] engagements


"Roche continues strong momentum with 7% growth (CER) in the first half of [----] full-year outlook confirmed. For more details on our performance click here ➡ $ROG $RHHBY #RocheFinancialResults https://go.roche.com/xhyr https://go.roche.com/xhyr"  
[X Link](https://x.com/Roche/status/1948248354464379332)  2025-07-24T05:06Z 240.7K followers, [----] engagements


"#MEDIA - Were pleased to share new insights in Alzheimer's disease research across our diagnostics and treatment pipelines at #AAIC25. The new data underscores Roches uniquely integrated end-to-end approach to addressing Alzheimers. $RHHBY $ROG https://www.roche.com/media https://www.roche.com/media"  
[X Link](https://x.com/Roche/status/1949744279418454278)  2025-07-28T08:10Z 240.8K followers, [----] engagements


"#MEDIA - We are pleased to be presenting new five-year data at #ASRS2025 today. These data highlight that our refillable eye implant continues to provide long-term vision outcomes in neovascular age-related macular degeneration (nAMD) - the leading cause of vision loss in people aged over [--]. https://www.roche.com/media/releases/med-cor-2025-08-01 https://www.roche.com/media/releases/med-cor-2025-08-01"  
[X Link](https://x.com/Roche/status/1951414831463940600)  2025-08-01T22:48Z 241K followers, [----] engagements


"#MEDIA Excited to announce that we entered into a definitive merger agreement with 89bio a key step in tackling Metabolic Dysfunction-Associated Steatohepatitis (MASH) a serious liver disease linked to obesity. This move enhances our CVRM portfolio and deepens our commitment to metabolic health. Read more: https://spkl.io/6018AR06n https://spkl.io/6018AR06n"  
[X Link](https://x.com/Roche/status/1968541313265029401)  2025-09-18T05:03Z 240.8K followers, [----] engagements


"Sequencing breakthroughs are within reach 🚀 Roche's SBX technology is set to accelerate genomics research while maintaining top quality and performance. What do you see as the biggest advantage of faster high-quality sequencing data analysis #Genomics #Science #Biotech Faster diagnoses Accelerate drug discovery All of the above Efficient research flows Faster diagnoses Accelerate drug discovery All of the above Efficient research flows"  
[X Link](https://x.com/Roche/status/1968996385308422537)  2025-09-19T11:11Z 240.8K followers, [----] engagements


"The answer is all of the above Faster flexible and high-quality sequencing data analysis has the potential to bring incredible benefits to the world of science and healthcare Find out more here: https://go.roche.com/xsbxdapoll https://go.roche.com/xsbxdapoll"  
[X Link](https://x.com/Roche/status/1971486858740965489)  2025-09-26T08:07Z 240.8K followers, [---] engagements


"Honored to see @HansClevers recognized Abarca Prize in Spain A remarkable achievement that demonstrates how science and compassion go hand in hand. Find out more about #AbarcaPrize #ResearchPrize #EarlyDevelopment #MedicalResearch https://spkl.io/6013ApTSd https://spkl.io/6013ApTSd"  
[X Link](https://x.com/Roche/status/1973424426956751133)  2025-10-01T16:27Z 240.7K followers, 15.5K engagements


"@msdrx Glad you like it - thanks for the kind feedback"  
[X Link](https://x.com/Roche/status/299553983679307776)  2013-02-07T16:23Z 242.3K followers, [--] engagements


"Roche employees around the world walk for children in Malawi and raise funds http://t.co/4MbR7wxixW #RoCW via @yellowdayzy - South Africa http://ow.ly/y4Tyf http://ow.ly/y4Tyf"  
[X Link](https://x.com/Roche/status/478553944873263104)  2014-06-16T15:05Z 245.3K followers, [--] engagements


"Don't miss #ESMO14 Presidential Session in Room Madrid 4pm CET for discussion of our new #breastcancer data: http://t.co/cLclWfo5JF http://ow.ly/C2jGE http://ow.ly/C2jGE"  
[X Link](https://x.com/Roche/status/516216521388208129)  2014-09-28T13:23Z 245.3K followers, [--] engagements


"Roche reports strong results in 2015: $ROG $RHHBY #pharma http://ow.ly/XCF7f http://ow.ly/XCF7f"  
[X Link](https://x.com/Roche/status/692776921680199684)  2016-01-28T18:31Z 245.3K followers, [--] engagements


"Roche CEO Severin Schwan summarizes [----] full-year performance. $ROG $RHHBY"  
[X Link](https://x.com/Roche/status/826890377089028097)  2017-02-01T20:30Z 245.3K followers, [--] engagements


"In [----] Roches Group sales rose 4% at constant exchange rates to CHF [----] bn. $ROG $RHHBY"  
[X Link](https://x.com/Roche/status/826901706659110912)  2017-02-01T21:15Z 245.8K followers, [--] engagements


"What life with #RheumatoidArthritis really looks like. A young artist from Slovenia shares his story. #WAAD17 http://ow.ly/p8O330bRQGd http://ow.ly/p8O330bRQGd"  
[X Link](https://x.com/Roche/status/865864709634961408)  2017-05-20T09:40Z 245.2K followers, [--] engagements


"#Media: #Innovation in HIV testing is increasing access to testing for patients living in remote locations. https://cards.twitter.com/cards/18ce53vuuym/5775m https://cards.twitter.com/cards/18ce53vuuym/5775m"  
[X Link](https://x.com/Roche/status/949650542107783169)  2018-01-06T14:35Z 241K followers, [--] engagements


"Pharma sales rose 5% at constant exchange rates to CHF [----] bn. New products drove 65% of divisional growth. $ROG $RHHBY"  
[X Link](https://x.com/Roche/status/958946405086826498)  2018-02-01T06:13Z 245.3K followers, [--] engagements


"In [----] both our Pharmaceuticals and Diagnostics Divisions showed good growth. $ROG $RHHBY"  
[X Link](https://x.com/Roche/status/958990799613685760)  2018-02-01T09:09Z 245.3K followers, [--] engagements


"Find out about our contributions to a healthier society. Take a journey through the stories behind the numbers in our annual report. $ROG $RHHBY"  
[X Link](https://x.com/Roche/status/958992414550700032)  2018-02-01T09:16Z 245.3K followers, [--] engagements


"Roche Group sales increased 5% at constant exchange rates to CHF [----] billion in [----]. $ROG $RHHBY"  
[X Link](https://x.com/Roche/status/959137359488045056)  2018-02-01T18:52Z 245.3K followers, [--] engagements


"We're proud to announce our acquisition with @flatironhealth to accelerate industry-wide development and delivery of breakthrough medicines for patients with #cancer. $ROG $RHHBY http://ow.ly/hnm730irex4 http://ow.ly/hnm730irex4"  
[X Link](https://x.com/Roche/status/964424209244958723)  2018-02-16T09:00Z 245.3K followers, [--] engagements


"We're proud to announce our acquisition with @flatironhealth. By coming together with Flatiron we'll leverage our combined expertise to advance the use of real-world evidence to set new industry standards for #oncology research and development. $ROG $RHHBY http://ow.ly/YDeJ30irhXh http://ow.ly/YDeJ30irhXh"  
[X Link](https://x.com/Roche/status/964468180210126848)  2018-02-16T11:55Z 245.3K followers, [---] engagements


"Roche receives EU approval for its treatment for #hemophilia A with inhibitors. $ROG $RHHBY http://ow.ly/y9JY30iE5kX http://ow.ly/y9JY30iE5kX"  
[X Link](https://x.com/Roche/status/968527468889026560)  2018-02-27T16:45Z 245.3K followers, [--] engagements


"Roche announces positive results from a Phase III cancer #immunotherapy combination study for the initial treatment of #lungcancer. $ROG $RHHBY http://ow.ly/z5Jv30j2Pwd http://ow.ly/z5Jv30j2Pwd"  
[X Link](https://x.com/Roche/status/976003306110750721)  2018-03-20T07:51Z 245.3K followers, [--] engagements


"We're happy to announce that as of today our acquisition with Flatiron Health is complete. $ROG $RHHBY #oncology"  
[X Link](https://x.com/Roche/status/982192476789268480)  2018-04-06T09:45Z 245.4K followers, [--] engagements


"The leap to tomorrow is today 🚀 Roche's new Diagnostics Innovation Center in Penzberg Germany is now officially open. This 300M investment is a massive step for innovation designed for collaboration and digitalization to accelerate test development. Better diagnostics = better lives for patients globally: #Innovation #LEAP #Penzberg #Healthcare #Technology https://go.roche.com/leapx https://go.roche.com/leapx"  
[X Link](https://x.com/anyuser/status/2021880120340889656)  2026-02-12T09:32Z 238.3K followers, [----] engagements


"Sequencing by expansion (SBX) is built to unlock opportunities that were once out of reach. From delivering full-length reads with unmatched speed to supporting transformative research SBX currently in development at Roche sets a new benchmark for next-generation sequencing. Watch the full video to find out more about how SBX is different from another popular sequencing technology #Genomics #HumanGenetics #RocheSBX #Innovation #NGS https://go.roche.com/xsbxs https://go.roche.com/xsbxs"  
[X Link](https://x.com/anyuser/status/2021661559601168712)  2026-02-11T19:04Z 238.3K followers, [----] engagements


"MEDIA - Were pleased to share new Phase III data at #ACTRIMSForum for our investigational medicine in primary progressive multiple sclerosis. $RHHBY $ROG https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/anyuser/status/2020436289854824688)  2026-02-08T09:55Z 238.3K followers, [----] engagements


"Roche reports strong [----] results with 7% (CER) sales growth driven by strong demand for medicines and diagnostic solutions. 👉 Read the full release here: $ROG $RHHBY #FinancialResults https://spkl.io/6010AqN8r https://spkl.io/6010AqN8r"  
[X Link](https://x.com/anyuser/status/2016753185507901622)  2026-01-29T06:00Z 238.3K followers, [----] engagements


"It's #CervicalCancerAwarenessMonth & we need to face the facts: No woman should die from cervical cancer. This disease is highly preventable yet hundreds of thousands of families still experience this devastating loss every year. #ScreeningSavesLives"  
[X Link](https://x.com/anyuser/status/2008810842993676415)  2026-01-07T08:00Z 238.3K followers, [----] engagements


"#MEDIA We are pleased to announce that the US FDA has approved our bispecific antibody for subcutaneous administration for people with relapsed or refractory #lymphoma reducing administration time from 2-4 hours to approximately one minute. $RHHBY $ROG https://spkl.io/6011AY8Af https://spkl.io/6011AY8Af"  
[X Link](https://x.com/anyuser/status/2003046611946021352)  2025-12-22T10:15Z 238.3K followers, [----] engagements


"Do you know how mass spectrometry can be used for therapeutic drug monitoring Enter a new dimension in mass spectrometry and find out how this diagnostic technique can help critically ill patients attain target concentrations. #RocheMassSpec https://go.roche.com/xtdms https://go.roche.com/xtdms"  
[X Link](https://x.com/anyuser/status/2001563093646671894)  2025-12-18T08:00Z 238.3K followers, [----] engagements


"The future of faster drug discovery may be on the horizon. #Organoids tiny simplified versions of human tissues help us test potential medicines in faster more predictive ways. A new review with @Hubrecht Institute explores how. 👏 Thank you to the scientists driving this work. Read more 👉 #DrugDiscovery #Innovation #pRED @IHB_Research @Hans Clevers https://spkl.io/6017Ai1dt https://spkl.io/6017Ai1dt"  
[X Link](https://x.com/anyuser/status/1999373655956918700)  2025-12-12T07:00Z 238.3K followers, [----] engagements


"#MEDIA - Roche receives CE mark approval for its automated mass spectrometry reagent pack for antibiotics drug monitoring offering the industry's broadest #IVD menu on the mass spec platform. #RocheMassSpec $ROG $RHHBY https://go.roche.com/xprmstdm https://go.roche.com/xprmstdm"  
[X Link](https://x.com/anyuser/status/1998997926626947421)  2025-12-11T06:06Z 238.3K followers, [----] engagements


"#MEDIA Were excited to present transformational phase III data at #SABCS25 on our oral #SERD vs. standard-of-care therapy in ER-positive early-stage #BreastCancer $ROG $RHHBY http://roche.com/media/releases http://roche.com/media/releases"  
[X Link](https://x.com/anyuser/status/1998769677485416894)  2025-12-10T15:00Z 238.3K followers, [----] engagements


"#MEDIA - We are pleased our medicine for adults with active #lupusnephritis is approved in the EU providing those living with this potentially life-threatening disease with a much-needed new treatment option and potential new standard of care. $ROG $RHHBY https://spkl.io/6012A9kmi https://spkl.io/6012A9kmi"  
[X Link](https://x.com/anyuser/status/1998327720976031844)  2025-12-09T09:43Z 238.3K followers, [----] engagements


"#MEDIA Were pleased to present new data highlighting the potential of our fixed-duration bispecific antibody in earlier treatment lines for people living with indolent and aggressive #lymphoma #ASH25 👉 $ROG $RHHBY https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/anyuser/status/1998286492460880242)  2025-12-09T07:00Z 238.3K followers, [----] engagements


"#MEDIA Were pleased to share three-year follow-up data from our off-the-shelf bispecific-combination which reinforce its potential to improve outcomes for people with an aggressive form of #lymphoma #ASH25 👉 $ROG $RHHBY https://www.roche.com/media/releases https://www.roche.com/media/releases"  
[X Link](https://x.com/anyuser/status/1998054403593343467)  2025-12-08T15:37Z 238.3K followers, [----] engagements


"As the needs and expectations of people living with haemophilia A continue to evolve Roches John Pasi explores how we can build on past breakthroughs to deliver more personalised care. Read the full story 👉 #HaemophiliaA #ASH2025 #PatientCentricity #InnovationInCare https://spkl.io/6015AgLZX https://spkl.io/6015AgLZX"  
[X Link](https://x.com/anyuser/status/1997924106818191805)  2025-12-08T07:00Z 238.3K followers, [----] engagements


"Whooping cough (pertussis) results with PCR-level accuracy are now available at the point of care enabling primary care clinicians & emergency departments to act quickly treat appropriately prevent complications and control further spread. $RHHBY $ROG https://www.roche.com/media https://www.roche.com/media"  
[X Link](https://x.com/anyuser/status/1995771269510201395)  2025-12-02T08:25Z 238.3K followers, [----] engagements


"Were proud to stand with the global scientific community at #CTAD2025 to advance whats possible in #Alzheimers care. For over [--] years Roche has worked to change the trajectory of the disease - from early detection to ongoing care. 👉 Learn how were charting a new course in Alzheimers care: https://spkl.io/6010A5VX6 https://spkl.io/6010A5VX6"  
[X Link](https://x.com/anyuser/status/1995387391297679694)  2025-12-01T07:00Z 238.3K followers, [----] engagements


"Our #ChangingDiabetesInChildren initiative in collaboration with @novonordisk has spent [--] years empowering T1D care in resource-limited countries through education & access. Now we're leveraging evidence-based insights to embed sustainable care into national health plans. Witness our impact: #diabetesinchildren #DiabetesCare #HealthEquity https://go.roche.com/cdicx https://go.roche.com/cdicx"  
[X Link](https://x.com/anyuser/status/1994058636331458634)  2025-11-27T15:00Z 238.3K followers, [----] engagements


"#MEDIA Were pleased to announce that the EC has approved our bispecific cancer immunotherapy for subcutaneous use in relapsed or refractory #lymphoma providing an additional treatment option to suit diverse patient and physician needs. 👉 https://spkl.io/6016AduYQ https://spkl.io/6016AduYQ"  
[X Link](https://x.com/anyuser/status/1991084695019294811)  2025-11-19T10:02Z 238.3K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing